Antibody-Drug Conjugates: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 December 2023

  • curprev 05:1405:14, 16 December 2023Ai talk contribs 3,355 bytes +3,355 Created page with "== Introduction == Antibody-drug conjugates (ADCs) are a class of biopharmaceutical drugs designed as targeted therapies for treating patients with cancer. They are complex molecules composed of an antibody linked to a biologically active cytotoxic (anti-cancer) drug. Through the use of a linker, these two components form a stable ADC that can target and kill cancer cells while sparing healthy cells. == Structure and Mechanism of Ac..."